MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has received the 2025 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. Recognized since 2012, Henry Schein is one of three honor...
HSIC shows bullish price action, momentum, volume, and relative strength, making it an attractive investment with a 2.6 reward-to-risk ratio. The stock is in an uptrend, trading above its 30-week EMA, and has bullish short-term and long-term momentum as indicated by the PPO. Institutional buying supports bullish volume trends, and HSIC has been outperforming the S&P 500 since December 2024.
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisiti...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the Leerink Global Healthcare Conference on Tuesday, March 11th, 2025, at the W South Beach hotel in Miami at 1:40 p.m. Eastern time. Henry Schein's presentations can be heard ...
MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2025 Rising Star Award. Created in 2021, the annual Award honors emerging athletic trainers who have one to five years of experience in t...
Henry Schein, Inc. (NASDAQ:HSIC ) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Graham Stanley - Vice President of Investor Relations & Strategic Financial Project Officer Stanley Bergman - Chairman & Chief Executive Officer Ronald South - Senior Vice President & Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Jeffrey Johnso...
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial results and guidance being provided today are consistent with the preliminary financial results and guidance provide...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.